179 related articles for article (PubMed ID: 30295769)
1. Trends in antifungal use in US hospitals, 2006-12.
Vallabhaneni S; Baggs J; Tsay S; Srinivasan AR; Jernigan JA; Jackson BR
J Antimicrob Chemother; 2018 Oct; 73(10):2867-2875. PubMed ID: 30295769
[TBL] [Abstract][Full Text] [Related]
2. Consumption of systemic antifungal agents among acute care hospitals in Catalonia (Spain), 2008-2013.
Fondevilla E; Grau S; Mojal S; Palomar M; Matas L; Gudiol F;
Expert Rev Anti Infect Ther; 2016; 14(1):137-44. PubMed ID: 26466197
[TBL] [Abstract][Full Text] [Related]
3. Antifungal use in hospitalized adults in U.S. academic health centers.
Pakyz AL; Gurgle HE; Oinonen MJ
Am J Health Syst Pharm; 2011 Mar; 68(5):415-8. PubMed ID: 21330683
[TBL] [Abstract][Full Text] [Related]
4. Antifungals in Clinical Use and the Pipeline.
Johnson MD
Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281
[TBL] [Abstract][Full Text] [Related]
5. Antifungal stewardship in daily practice and health economic implications.
Muñoz P; Valerio M; Vena A; Bouza E
Mycoses; 2015 Jun; 58 Suppl 2():14-25. PubMed ID: 26033252
[TBL] [Abstract][Full Text] [Related]
6. Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012.
Baggs J; Fridkin SK; Pollack LA; Srinivasan A; Jernigan JA
JAMA Intern Med; 2016 Nov; 176(11):1639-1648. PubMed ID: 27653796
[TBL] [Abstract][Full Text] [Related]
7. Systemic antifungal drug use in Belgium-One of the biggest antifungal consumers in Europe.
Goemaere B; Lagrou K; Spriet I; Hendrickx M; Vandael E; Becker P; Catry B
Mycoses; 2019 Jun; 62(6):542-550. PubMed ID: 30887582
[TBL] [Abstract][Full Text] [Related]
8. [Antifungals for systemic use].
Ruiz-Camps I; Cuenca-Estrella M
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382
[TBL] [Abstract][Full Text] [Related]
9. Management of invasive fungal infections: a role for polyenes.
Chandrasekar P
J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
[TBL] [Abstract][Full Text] [Related]
10. Choosing the Right Antifungal Agent in ICU Patients.
Chatelon J; Cortegiani A; Hammad E; Cassir N; Leone M
Adv Ther; 2019 Dec; 36(12):3308-3320. PubMed ID: 31617055
[TBL] [Abstract][Full Text] [Related]
11. Variability in antifungal utilization among neonatal, pediatric, and adult inpatients in academic medical centers throughout the United States of America.
Stultz JS; Kohinke R; Pakyz AL
BMC Infect Dis; 2018 Oct; 18(1):501. PubMed ID: 30285738
[TBL] [Abstract][Full Text] [Related]
12. Correlation between antifungal consumption and the distribution of Candida species in different hospital departments of a Lebanese medical Centre.
Awad L; Tamim H; Abdallah D; Salameh M; Mugharbil A; Jisr T; Zahran K; Droubi N; Ibrahim A; Moghnieh R
BMC Infect Dis; 2018 Nov; 18(1):589. PubMed ID: 30453891
[TBL] [Abstract][Full Text] [Related]
13. Trends in the utilization of, spending on, and prices for outpatient antifungal agents in US Medicaid programs: 1991-2009.
Desai VC; Cavanaugh TM; Kelton CM; Guo JJ; Heaton PC
Clin Ther; 2012 Oct; 34(10):2118-2131.e1. PubMed ID: 23031625
[TBL] [Abstract][Full Text] [Related]
14. Recent approaches to antifungal therapy for invasive mycoses.
Mathew BP; Nath M
ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
[TBL] [Abstract][Full Text] [Related]
15. Antifungals to treat Candida albicans.
Moudgal V; Sobel J
Expert Opin Pharmacother; 2010 Aug; 11(12):2037-48. PubMed ID: 20536294
[TBL] [Abstract][Full Text] [Related]
16. Antifungal therapeutics for dimorphic fungal pathogens.
Goughenour KD; Rappleye CA
Virulence; 2017 Feb; 8(2):211-221. PubMed ID: 27646561
[TBL] [Abstract][Full Text] [Related]
17. [Trends in systemic antifungal use in critically ill patients. Multicenter observational study, 2006-2010].
Olaechea-Astigarraga PM; Alvarez-Lerma F; Palomar-Martínez M; Insausti-Ordeñana J; López-Pueyo MJ; Seijas-Betolaza I; Otal-Entraigas JJ; Gimeno-Costa R; Gracia-Arnillas MP;
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):435-40. PubMed ID: 22463989
[TBL] [Abstract][Full Text] [Related]
18. Current options in antifungal pharmacotherapy.
Mohr J; Johnson M; Cooper T; Lewis JS; Ostrosky-Zeichner L
Pharmacotherapy; 2008 May; 28(5):614-45. PubMed ID: 18447660
[TBL] [Abstract][Full Text] [Related]
19. Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?
Le A; Farmakiotis D; Tarrand JJ; Kontoyiannis DP
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584138
[TBL] [Abstract][Full Text] [Related]
20. The value of amphotericin B in the treatment of invasive fungal infections.
Klepser M
J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
